Payment overview · 2025
General Payments
$17.80
1 reported records · 1 companies
Healthcare provider profile · identity verified
Jorge Alejandro Rodriguez, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · YAUCO, PR · NPI 1023239001
Verified facts
What the public records show
CMS Open Payments records show Jorge Alejandro Rodriguez, M.D. received $17.80 in general payments during 2025 across 1 reported records.
AstraZeneca Pharmaceuticals LP accounted for 100.0% of that reported general-payment amount.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 185 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Symbicort by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $17.80 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $17.80 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
16 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
185 | 62 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
17 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Gabapentin | Gabapentin | 1117 | 186 |
| Levothyroxine Sodium | Levothyroxine Sodium | 745 | 108 |
| Atorvastatin Calcium | Atorvastatin Calcium | 573 | 195 |
| Pantoprazole Sodium | Pantoprazole Sodium | 534 | 128 |
| Famotidine | Famotidine | 507 | 100 |
| Montelukast Sodium | Montelukast Sodium | 467 | 82 |
| Alendronate Sodium | Alendronate Sodium | 429 | 74 |
| Synthroid | Levothyroxine Sodium | 428 | 65 |
| Simvastatin | Simvastatin | 382 | 126 |
| Tamsulosin Hcl | Tamsulosin Hcl | 370 | 75 |
| Metformin Hcl | Metformin Hcl | 315 | 91 |
| Amlodipine Besylate | Amlodipine Besylate | 313 | 113 |
| Losartan Potassium | Losartan Potassium | 299 | 107 |
| Levofloxacin | Levofloxacin | 270 | 198 |
| Metoprolol Succinate | Metoprolol Succinate | 266 | 88 |
| Glimepiride | Glimepiride | 255 | 77 |
| Allopurinol | Allopurinol | 218 | 39 |
| Omeprazole | Omeprazole | 208 | 43 |
| Cilostazol | Cilostazol | 193 | 40 |
| Clopidogrel | Clopidogrel Bisulfate | 185 | 69 |
| Farxiga | Dapagliflozin Propanediol | 185 | 62 |
| Meloxicam | Meloxicam | 174 | 107 |
| Lisinopril | Lisinopril | 171 | 63 |
| Carvedilol | Carvedilol | 170 | 60 |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 158 | 23 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 146 | 54 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 141 | 29 |
| Donepezil Hcl | Donepezil Hcl | 139 | 31 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 134 | 45 |
| Furosemide | Furosemide | 119 | 43 |
| Azithromycin | Azithromycin | 118 | 100 |
| Clonazepam | Clonazepam | 116 | 36 |
| Finasteride | Finasteride | 107 | 24 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 101 | 64 |
| Ezetimibe | Ezetimibe | 101 | 37 |
| Doxazosin Mesylate | Doxazosin Mesylate | 98 | 32 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 94 | 32 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 92 | 24 |
| Prednisone | Prednisone | 88 | 33 |
| Fenofibrate | Fenofibrate | 87 | 31 |
| Xarelto | Rivaroxaban | 85 | 36 |
| Glipizide | Glipizide | 84 | 28 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 84 | 29 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 84 | 17 |
| Sertraline Hcl | Sertraline Hcl | 77 | 14 |
| Trazodone Hcl | Trazodone Hcl | 77 | 27 |
| Candesartan Cilexetil | Candesartan Cilexetil | 76 | 27 |
| Memantine Hcl | Memantine Hcl | 76 | 19 |
| Hydralazine Hcl | Hydralazine Hcl | 72 | 22 |
| Warfarin Sodium | Warfarin Sodium | 69 | suppressed |
| Candesartan-Hydrochlorothiazid | Candesartan/Hydrochlorothiazid | 67 | 20 |
| Hydrochlorothiazide | Hydrochlorothiazide | 66 | 21 |
| Escitalopram Oxalate | Escitalopram Oxalate | 64 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 63 | 22 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 63 | suppressed |
| Atenolol | Atenolol | 62 | 23 |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 62 | 14 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 62 | 16 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 61 | 23 |
| Meclizine Hcl | Meclizine Hcl | 58 | 32 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 57 | 21 |
| Alprazolam | Alprazolam | 54 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 53 | suppressed |
| Irbesartan | Irbesartan | 50 | 19 |
| Paroxetine Hcl | Paroxetine Hcl | 50 | suppressed |
| Mupirocin | Mupirocin | 49 | 48 |
| Oxybutynin Chloride | Oxybutynin Chloride | 49 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 48 | 16 |
| Jentadueto | Linagliptin/Metformin Hcl | 48 | 16 |
| Diclofenac Sodium | Diclofenac Sodium | 46 | 30 |
| Temazepam | Temazepam | 45 | 15 |
| Tolterodine Tartrate | Tolterodine Tartrate | 44 | suppressed |
| Eliquis | Apixaban | 43 | 23 |
| Spironolactone | Spironolactone | 42 | 19 |
| Latanoprost | Latanoprost | 40 | suppressed |
| Indapamide | Indapamide | 39 | 16 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 39 | 15 |
| Nifedipine Er | Nifedipine | 39 | 17 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 38 | 18 |
| Fenofibrate | Fenofibrate Nanocrystallized | 38 | 14 |
| Ibandronate Sodium | Ibandronate Sodium | 38 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 38 | 16 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 37 | suppressed |
| Jardiance | Empagliflozin | 36 | 11 |
| Lansoprazole | Lansoprazole | 36 | suppressed |
| Metronidazole | Metronidazole | 35 | 31 |
| Glipizide Er | Glipizide | 34 | 11 |
| Chlorthalidone | Chlorthalidone | 32 | 12 |
| Amitriptyline Hcl | Amitriptyline Hcl | 31 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 31 | 23 |
| Pioglitazone Hcl | Pioglitazone Hcl | 31 | suppressed |
| Ramipril | Ramipril | 31 | suppressed |
| Baclofen | Baclofen | 30 | 13 |
| Enalapril Maleate | Enalapril Maleate | 30 | 12 |
| Pioglitazone-Metformin | Pioglitazone Hcl/Metformin Hcl | 30 | suppressed |
| Sucralfate | Sucralfate | 30 | 14 |
| Nabumetone | Nabumetone | 29 | 21 |
| Verapamil Er | Verapamil Hcl | 29 | suppressed |
| Fluconazole | Fluconazole | 28 | 24 |
| Fluoxetine Hcl | Fluoxetine Hcl | 28 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 27 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 26 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 25 | 21 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 25 | 19 |
| Etodolac | Etodolac | 25 | 14 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 25 | suppressed |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 25 | 24 |
| Trueplus Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 24 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 24 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 23 | 14 |
| Diltiazem Hcl | Diltiazem Hcl | 23 | suppressed |
| Ursodiol | Ursodiol | 23 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 22 | 17 |
| Dexamethasone | Dexamethasone | 22 | 16 |
| Raloxifene Hcl | Raloxifene Hcl | 22 | suppressed |
| Anastrozole | Anastrozole | 21 | suppressed |
| Digoxin | Digoxin | 21 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 21 | suppressed |
| Lorazepam | Lorazepam | 21 | suppressed |
| Ibuprofen | Ibuprofen | 20 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 19 | suppressed |
| Ketoconazole | Ketoconazole | 19 | 17 |
| Nitroglycerin | Nitroglycerin | 19 | 18 |
| Bupropion Xl | Bupropion Hcl | 18 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 18 | suppressed |
| Amlodipine-Atorvastatin | Amlodipine/Atorvastatin | 17 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 17 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 17 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 17 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 17 | suppressed |
| Januvia | Sitagliptin Phosphate | 17 | suppressed |
| Sulindac | Sulindac | 17 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Brilinta | Ticagrelor | 16 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 16 | suppressed |
| Naproxen | Naproxen | 16 | 12 |
| Valsartan | Valsartan | 16 | suppressed |
| Humalog | Insulin Lispro | 15 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 15 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 15 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 14 | suppressed |
| Folic Acid | Folic Acid | 14 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 14 | 14 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 14 | 12 |
| Albuterol Sulfate | Albuterol Sulfate | 13 | 13 |
| Amoxicillin | Amoxicillin | 13 | 12 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 13 | suppressed |
| Metolazone | Metolazone | 13 | suppressed |
| Mirtazapine | Mirtazapine | 13 | suppressed |
| Pentoxifylline | Pentoxifylline | 13 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 13 | suppressed |
| Risperidone | Risperidone | 13 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 13 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 12 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 12 | 12 |
| Enulose | Lactulose | 12 | suppressed |
| Insulin Lispro | Insulin Lispro | 12 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 12 | suppressed |
| Telmisartan | Telmisartan | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 11 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Bumetanide | Bumetanide | 11 | suppressed |
| Calcitriol | Calcitriol | 11 | suppressed |
| Carbamazepine | Carbamazepine | 11 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 11 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 11 | suppressed |
| Potassium Chloride | Potassium Chloride | 11 | 11 |
| Pravastatin Sodium | Pravastatin Sodium | 11 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 11 | suppressed |
| Synjardy | Empagliflozin/Metformin Hcl | 11 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $17.80 · 1 records | AstraZeneca Pharmaceuticals LP | — | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error